blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1429730

EP1429730 - OPIOID FORMULATIONS HAVING REDUCED POTENTIAL FOR ABUSE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.06.2015
Database last updated on 05.10.2024
Most recent event   Tooltip19.06.2015Application deemed to be withdrawnpublished on 22.07.2015  [2015/30]
Applicant(s)For all designated states
Penwest Pharmaceuticals Company
2981 Route 22
Patterson, NY 12563-9970 / US
[2004/26]
Inventor(s)01 / BAICHWAL, Anand, R.
5 Kendall Drive
Wappingers Falls, NY 12590 / US
02 / MCCALL, Troy, W.
8861 Three Chimneys Drive East
Germantown, TN 38138 / US
03 / WOODCOCK, Paul, M.
31 Mist Hill Drive
Brookfield, CT 06804 / US
 [2004/26]
Representative(s)Lau, Sarah Jane, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2014/45]Lau, Sarah Jane, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Former [2004/26]Bassil, Nicholas Charles, et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date02773571.125.09.2002
[2004/26]
WO2002US30393
Priority number, dateUS20010324546P26.09.2001         Original published format: US 324546 P
[2004/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03026743
Date:03.04.2003
Language:EN
[2003/14]
Type: A2 Application without search report 
No.:EP1429730
Date:23.06.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 03.04.2003 takes the place of the publication of the European patent application.
[2004/26]
Search report(s)International search report - published on:US16.10.2003
(Supplementary) European search report - dispatched on:EP20.05.2010
ClassificationIPC:A61K9/14, A61K9/16, A61K9/50, // A61K9/20, A61K9/28
[2010/24]
CPC:
A61K9/205 (EP,US); A61K31/485 (EP,US); A61P1/00 (EP);
A61P25/04 (EP); A61K9/2009 (EP,US); A61K9/2013 (EP,US);
A61K9/2018 (EP,US); A61K9/2027 (EP,US); A61K9/2866 (EP,US) (-)
Former IPC [2004/26]A61K9/14, A61K9/16, A61K9/50
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/26]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:OPIOID-FORMULIERUNGEN MIT VERRINGERTEM MISSBRAUCHSPOTENZIAL[2004/26]
English:OPIOID FORMULATIONS HAVING REDUCED POTENTIAL FOR ABUSE[2004/26]
French:FORMULATIONS D'OPIOIDES PRESENTANT UN POTENTIEL REDUIT POUR DES UTILISATIONS ABUSIVES[2004/26]
Entry into regional phase06.04.2004National basic fee paid 
06.04.2004Search fee paid 
06.04.2004Designation fee(s) paid 
06.04.2004Examination fee paid 
Examination procedure27.03.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
06.04.2004Examination requested  [2004/26]
17.08.2010Amendment by applicant (claims and/or description)
20.01.2011Despatch of a communication from the examining division (Time limit: M06)
26.07.2011Reply to a communication from the examining division
03.09.2014Despatch of a communication from the examining division (Time limit: M04)
14.01.2015Application deemed to be withdrawn, date of legal effect  [2015/30]
11.02.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/30]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.01.2011
Fees paidRenewal fee
04.10.2004Renewal fee patent year 03
21.09.2005Renewal fee patent year 04
27.09.2006Renewal fee patent year 05
26.09.2007Renewal fee patent year 06
25.09.2008Renewal fee patent year 07
25.09.2009Renewal fee patent year 08
27.09.2010Renewal fee patent year 09
08.09.2011Renewal fee patent year 10
25.09.2012Renewal fee patent year 11
09.09.2013Renewal fee patent year 12
08.09.2014Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
30.09.200403   M06   Fee paid on   04.10.2004
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO9528916  (MENDELL CO INC EDWARD [US], et al) [X] 1-3,6-11,13-15,18-23,25 * abstract * * examples 1-3 * * page 4, line 27 - page 5, line 33 * * page 7, line 7 - line 32 * * page 12, line 23 - line 25 * * claims 10,11 *[I] 4,5,12,16,17,24,26-33;
 [XI]US5958456  (BAICHWAL ANAND [US], et al) [X] 1,2,4,6-13,26,27,30-33 * abstract * * examples 1-12 * * column 6, lines 1-22,46-65 * * column 8, lines 29-30 * [I] 3,5,14-25,28,29
International search[Y]US6245357  (EDGREN DAVID E [US], et al)
ExaminationWO0108661
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.